Literature DB >> 33598691

Clonal hematopoiesis and therapy-related myeloid neoplasms following neuroblastoma treatment.

Tim H H Coorens1, Grace Collord1,2,3, Wanhua Lu4, Emily Mitchell1,4,5, Jannat Ijaz1, Thomas Roberts4, Thomas R W Oliver1, G A Amos Burke4, Michael Gattens4, Emmy Dickens4, Jyoti Nangalia1,4,5,6, Marc Tischkowitz7, John Anderson8,9, Adam Shlien10, Anna L Godfrey4, Matthew J Murray4,11, Sam Behjati1,4,12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33598691      PMCID： PMC8160503          DOI： 10.1182/blood.2020010150

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  24 in total

1.  From initiation to eradication: the lifespan of an MLL-rearranged therapy-related paediatric AML.

Authors:  M Krumbholz; J Bradtke; D Stachel; O Peters; B Hero; W Holter; R Slany; M Metzler
Journal:  Bone Marrow Transplant       Date:  2015-07-06       Impact factor: 5.483

2.  Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes.

Authors:  Catherine C Coombs; Ahmet Zehir; Sean M Devlin; Ashwin Kishtagari; Aijazuddin Syed; Philip Jonsson; David M Hyman; David B Solit; Mark E Robson; José Baselga; Maria E Arcila; Marc Ladanyi; Martin S Tallman; Ross L Levine; Michael F Berger
Journal:  Cell Stem Cell       Date:  2017-08-10       Impact factor: 24.633

Review 3.  How I treat myelodysplastic syndromes of childhood.

Authors:  Franco Locatelli; Brigitte Strahm
Journal:  Blood       Date:  2018-02-08       Impact factor: 22.113

4.  The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.

Authors:  Hamid Bolouri; Jason E Farrar; Timothy Triche; Rhonda E Ries; Emilia L Lim; Todd A Alonzo; Yussanne Ma; Richard Moore; Andrew J Mungall; Marco A Marra; Jinghui Zhang; Xiaotu Ma; Yu Liu; Yanling Liu; Jaime M Guidry Auvil; Tanja M Davidsen; Patee Gesuwan; Leandro C Hermida; Bodour Salhia; Stephen Capone; Giridharan Ramsingh; Christian Michel Zwaan; Sanne Noort; Stephen R Piccolo; E Anders Kolb; Alan S Gamis; Malcolm A Smith; Daniela S Gerhard; Soheil Meshinchi
Journal:  Nat Med       Date:  2017-12-11       Impact factor: 53.440

5.  Embryonal precursors of Wilms tumor.

Authors:  Tim H H Coorens; Taryn D Treger; Reem Al-Saadi; Luiza Moore; Maxine G B Tran; Thomas J Mitchell; Suzanne Tugnait; Christine Thevanesan; Matthew D Young; Thomas R W Oliver; Minou Oostveen; Grace Collord; Patrick S Tarpey; Alex Cagan; Yvette Hooks; Mark Brougham; Ben C Reynolds; Giuseppe Barone; John Anderson; Mette Jorgensen; G A Amos Burke; Johannes Visser; James C Nicholson; Naima Smeulders; Imran Mushtaq; Grant D Stewart; Peter J Campbell; David C Wedge; Iñigo Martincorena; Dyanne Rampling; Liz Hook; Anne Y Warren; Nicholas Coleman; Tanzina Chowdhury; Neil Sebire; Jarno Drost; Kourosh Saeb-Parsy; Michael R Stratton; Karin Straathof; Kathy Pritchard-Jones; Sam Behjati
Journal:  Science       Date:  2019-12-06       Impact factor: 47.728

6.  Therapy-related myelodysplasia and acute myeloid leukemia after Ewing sarcoma and primitive neuroectodermal tumor of bone: A report from the Children's Oncology Group.

Authors:  Smita Bhatia; Mark D Krailo; Zhengjia Chen; Laura Burden; Frederic B Askin; Paul S Dickman; Holcombe E Grier; Michael P Link; Paul A Meyers; Elizabeth J Perlman; Aaron R Rausen; Leslie L Robison; Teresa J Vietti; James S Miser
Journal:  Blood       Date:  2006-09-19       Impact factor: 22.113

7.  Transient donor cell-derived myelodysplastic syndrome with monosomy 7 after unrelated cord blood transplantation.

Authors:  Julián Sevilla; Sergio Querol; Antonio Molines; Marta González-Vicent; Antonio Balas; Ana Carrió; Jesús Estella; Miguel Angel Díaz; Luis Madero
Journal:  Eur J Haematol       Date:  2006-09       Impact factor: 2.997

Review 8.  Neuroblastoma and treatment-related myelodysplasia/leukemia: the Memorial Sloan-Kettering experience and a literature review.

Authors:  B H Kushner; N K Cheung; K Kramer; G Heller; S C Jhanwar
Journal:  J Clin Oncol       Date:  1998-12       Impact factor: 44.544

9.  The mutational footprints of cancer therapies.

Authors:  Oriol Pich; Ferran Muiños; Martijn Paul Lolkema; Neeltje Steeghs; Abel Gonzalez-Perez; Nuria Lopez-Bigas
Journal:  Nat Genet       Date:  2019-11-18       Impact factor: 38.330

10.  Role of TP53 mutations in the origin and evolution of therapy-related acute myeloid leukaemia.

Authors:  Terrence N Wong; Giridharan Ramsingh; Andrew L Young; Christopher A Miller; Waseem Touma; John S Welch; Tamara L Lamprecht; Dong Shen; Jasreet Hundal; Robert S Fulton; Sharon Heath; Jack D Baty; Jeffery M Klco; Li Ding; Elaine R Mardis; Peter Westervelt; John F DiPersio; Matthew J Walter; Timothy A Graubert; Timothy J Ley; Todd Druley; Daniel C Link; Richard K Wilson
Journal:  Nature       Date:  2014-12-08       Impact factor: 49.962
View more
  7 in total

1.  Cancer predisposing syndrome: a retrospective cohort analysis in a pediatric and multidisciplinary genetic cancer counseling unit.

Authors:  Adela Escudero; Cristina Ferreras; Nuria Rodriguez-Salas; Dolores Corral; Laura Rodriguez; Antonio Pérez-Martínez
Journal:  Int J Clin Oncol       Date:  2022-02-21       Impact factor: 3.402

Review 2.  Clonal Hematopoiesis: Role in Hematologic and Non-Hematologic Malignancies.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-09-01       Impact factor: 3.122

3.  Elevated Mutational Age in Blood of Children Treated for Cancer Contributes to Therapy-Related Myeloid Neoplasms.

Authors:  Eline J M Bertrums; Axel K M Rosendahl Huber; Jurrian K de Kanter; Arianne M Brandsma; Anaïs J C N van Leeuwen; Mark Verheul; Marry M van den Heuvel-Eibrink; Rurika Oka; Markus J van Roosmalen; Hester A de Groot-Kruseman; C Michel Zwaan; Bianca F Goemans; Ruben van Boxtel
Journal:  Cancer Discov       Date:  2022-08-05       Impact factor: 38.272

Review 4.  Autologous Stem-Cell Transplantation for High-Risk Neuroblastoma: Historical and Critical Review.

Authors:  Jaume Mora
Journal:  Cancers (Basel)       Date:  2022-05-24       Impact factor: 6.575

5.  Baseline risk of hematologic malignancy at initiation of frontline PARP inhibitor maintenance for BRCA1/2-associated ovarian cancer.

Authors:  Anastasia Navitski; Duaa H Al-Rawi; Ying Liu; Maria M Rubinstein; Claire F Friedman; Raajit K Rampal; Diana L Mandelker; Karen Cadoo; Roisin E O'Cearbhaill
Journal:  Gynecol Oncol Rep       Date:  2021-10-05

6.  Single-cell transcriptomics reveals a distinct developmental state of KMT2A-rearranged infant B-cell acute lymphoblastic leukemia.

Authors:  Eleonora Khabirova; Laura Jardine; Tim H H Coorens; Simone Webb; Taryn D Treger; Justin Engelbert; Tarryn Porter; Elena Prigmore; Grace Collord; Alice Piapi; Sarah A Teichmann; Sarah Inglott; Owen Williams; Olaf Heidenreich; Matthew D Young; Karin Straathof; Simon Bomken; Jack Bartram; Muzlifah Haniffa; Sam Behjati
Journal:  Nat Med       Date:  2022-03-14       Impact factor: 87.241

7.  Common anti-cancer therapies induce somatic mutations in stem cells of healthy tissue.

Authors:  Ewart Kuijk; Onno Kranenburg; Edwin Cuppen; Arne Van Hoeck
Journal:  Nat Commun       Date:  2022-10-07       Impact factor: 17.694
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.